Table 1.

Patient characteristics (N = 640)

Male/female, n (%)	448 (68)/212 (32)
Age (years)	62.4 ± 14.2
BMI (kg/m2)	24.0 ± 3.9
Hypertension, n (%)	462 (70)
Diabetes mellitus, n (%)	179 (27)
HbA1c (%)	5.97 ± 0.76
Current smoking, n (%)	94 (14)
Dyslipidemia, n (%)	408 (62)
eGFR (ml/min/1.73 m2)	70.7 ± 18.4
CKD ≥ stage 3, n (%)	173 (27)
Number of risk factors	2.5 ± 1.4
Coronary artery disease, n (%)	145 (22)
Concomitant drug, n (%)
Anti-platelets	186 (28)
ACEs/ARBs	309 (47)
β blockers	140 (21)
Calcium channel blockers	333 (50)
Lipid-modifying drugs	324 (49)

BMI body mass index, Hb hemoglobin, eGFR estimated glomerular flow rate, CKD chronic kidney disease, ACE-I angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker